[Federal Register Volume 59, Number 103 (Tuesday, May 31, 1994)]
[Unknown Section]
[Page 0]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 94-13134]


[[Page Unknown]]

[Federal Register: May 31, 1994]


-----------------------------------------------------------------------


DEPARTMENT OF HEALTH AND HUMAN SERVICES
 

Preventing the Spread of Vancomycin Resistance; meeting

    The National Center for Infectious Diseases (NCID) of the Centers 
for Disease Control and Prevention (CDC) announces the following 
meeting.

    Name: Preventing the Spread of Vancomycin Resistance.
    Time and Date: 9 a.m.-2 p.m., June 15, 1994.
    Place: CDC, Auditorium B, 1600 Clifton Road, NE, Atlanta, 
Georgia 30333.
    Status: Open to the public, limited only by the space available.
    Purpose: The purpose of this open meeting is to receive verbal 
comments on a draft report entitled, ``Preventing the Spread of 
Vancomycin.'' This report from NCID's Hospital Infection Control 
Practices Advisory Committee (HICPAC) was published in 59 FR 25758, 
May 17, 1994, and contains preliminary recommendations for the 
prevention and control of the spread of vancomycin resistance, with 
special focus on vancomycin-resistant enterococci (VRE). It was 
prepared by HICPAC in collaboration with NCID and in consultation 
with representatives of the American Hospital Association, American 
Society for Microbiology, Association for Professionals in Infection 
Control and Epidemiology, Infectious Diseases Society of America, 
Society for Healthcare Epidemiology of America, and Surgical 
Infection Society.

    Viewpoints and suggestions regarding the draft recommendations are 
invited from other professional organizations, industry, academia, 
other government agencies, and the public. To obtain a five-minute time 
slot for presenting comments, please provide the following information 
to the contact person listed below no later than June 7, 1994: name, 
address, affiliation, and telephone and facsimile numbers. In addition, 
written comments on the draft recommendations are welcome and should be 
submitted on or before July 18, 1994, to CDC, Attention: VRE Report 
Center, Mailstop A-07, 1600 Clifton Road, NE, Atlanta, Georgia 30333, 
as outlined in 59 FR 25758, May 17, 1994.

    Contact person for more information: Julia S. Garner, R.N., 
M.N., Nurse Consultant, Hospital Infections Program, NCID, CDC, 1600 
Clifton Road, NE, Mailstop A-07, Atlanta, Georgia 30333, telephone 
404/639-1552 or facsimile 404/639-3838.

    Dated: May 24, 1994.
William H. Gimson,
Acting Asociate Director for Policy Coordination, Centers for Disease 
Control and Prevention (CDC).
[FR Doc. 94-13134 Filed 5-27-94; 8:45 am]
BILLING CODE 4163-18-M